Daniel Heller

Title: Daniel Heller: Inventor in Nanomedicine and Biomedical Imaging

Introduction

Daniel Heller is an inventor based in New York, NY, whose work explores nanomaterials and drug-delivery technologies for biomedical applications. He is affiliated with Memorial Sloan Kettering Cancer Center and is credited with 4 patents.

Latest Patents

Heller’s listed patent work includes “Helical polycarbodiimide polymers and associated imaging, diagnostic, and therapeutic methods.” The invention describes water-soluble, modifiable polymers that can cloak carbon nanotubes and influence their emission and sub-cellular localization. The polymers are also presented for potential use in radiopharmaceutical delivery, imaging, therapeutics, and sensing, including applications that do not use nanotubes.

Another listed patent is “Fucoidan nanogels and methods of their use and manufacture.” It describes drug-carrying nanogels designed to target P-selectin, which is associated with cancer and other diseases. In certain embodiments, the nanogels release drugs in response to the acidic environment around tumors, with the aim of improving targeting and potentially reducing the doses needed.

Career Highlights

At Memorial Sloan Kettering Cancer Center, Heller’s patent portfolio reflects research at the intersection of nanotechnology and medicine. The described inventions address biomedical imaging, sensing, targeted drug delivery, and therapeutic applications.

Collaborations

Heller’s listed coworkers include Yosef Shamay and Adriana Haimovitz-Friedman. Their names provide context for the collaborative research environment associated with his work.

Conclusion

Daniel Heller’s inventions focus on applying engineered polymers and nanogels to biomedical imaging and targeted therapies, highlighting the potential of nanotechnology in medical research.